Anemia in cardiac surgery: next target for mortality and morbidity improvement?
|
|
- Teresa Cunningham
- 6 years ago
- Views:
Transcription
1 Original Article Anemia in cardiac surgery: next target for mortality and morbidity improvement? Asian Cardiovascular & Thoracic Annals 2016, Vol. 24(1) ß The Author(s) 2015 Reprints and permissions: sagepub.co.uk/journalspermissions.nav DOI: / aan.sagepub.com Hari Padmanabhan 1, Dincer Aktuerk 2, Matthew J Brookes 1,3, Alan M Nevill 3, Alex Ng 4, James Cotton 5 and Heyman Luckraz 2 Abstract Objective: To assess the effects of preoperative anemia on outcomes of cardiac surgery and to explore the trend in mortality over an 8-year period. Methods: During the study period ( ), all 1170 patients undergoing elective or urgent cardiac surgery and classed as anemic were included. A matched group of non-anemic 1170 patients was used as a control group. Postoperative outcomes were compared between the 2 groups. The association between preoperative anemia and postoperative outcomes was analyzed using a logistic regression model. Results: Compared with patients without anemia, the need for airway support (15% vs. 12%, p ¼ 0.05), renal replacement therapy (13% vs. 8%, p < 0.01) and the rate of in-hospital surgical site infection (9% vs. 7%, p ¼ 0.05) were higher in the anemic group. Anemia was associated with greater need for renal replacement therapy (odds ratio ¼ 1.76, confidence interval: , p ¼ 0.002) and prolonged (> 7 days) hospital stay (odds ratio ¼ 1.21, confidence interval: , p ¼ 0.08). The blood transfusion rate (54% vs. 33%, p < 0.01) and hospital mortality (5.6% vs. 3.5%, p ¼ 0.02) were higher in the anemic group. Over the 8-year period, there was a significant improvement in mortality in the non-anemic group (from 6.5% to 1.6%) but less so in the anemic group (from 6.7% to 4.7%). Conclusion: Anemia impacts significantly on morbidity and mortality after cardiac surgery, with less improvement over time compared to patients without anemia. Preoperative correction of anemia, when feasible, could potentially help to improve cardiac surgery outcomes. Keywords Anemia, Cardiac surgical procedures, Blood transfusion, Hospital mortality, Length of stay Introduction Anemia has been reported to be associated with adverse postoperative outcomes, high cost to the healthcare system, and reduced survival after cardiac surgery. This association originated from observational studies. 1 7 Unfortunately, the available evidence has some limitations in relation to the criteria for anemia and the applicability to complex surgery. In some studies, only patients with severe anemia, with hemoglobin (Hb) < 10 g dl 1 or hematocrit < 30%, were selected, 2,8 whereas in others, patients with any degree of anemia were included. 1,3,5 The threshold for anemia in the latter studies was gender-specific and utilized the definition of the World Health Organization: Hb < 13 g dl 1 in men and <12 g dl 1 in women. 9 It is possible that patients with different degrees of anemia have concomitant variations in comorbidity and blood transfusion requirements, which would 1 Department of Gastroenterology, Heart & Lung Centre, Wolverhampton, UK 2 Department of Cardiothoracic Surgery, Heart & Lung Centre, Wolverhampton, UK 3 Research Institute of Healthcare Sciences, University of Wolverhampton, Wolverhampton, UK 4 Department of Cardiothoracic Anaesthesiology, Heart & Lung Centre, Wolverhampton, UK 5 Department of Cardiology, Heart & Lung Centre, Wolverhampton, UK Corresponding author: Hari Padmanabhan, Department of Gastroenterology, Royal Wolverhampton NHS Trust, Wolverhampton, WV10 0QP, United Kingdom. Hari.Padmanabhan@nhs.net
2 Padmanabhan et al. 13 confound any association between anemia and postoperative outcome. 2,3 The majority of available data seems to originate from patients who underwent surgical procedures such as coronary artery bypass grafting (CABG) rather than combined complex procedures. 2,3,5,7 In terms of applicability, there is a relative paucity of data regarding complex surgery in which patients are likely to be anemic and require blood transfusion. Furthermore, it seems that some past studies assessing the association between anemia and postoperative outcome, may not have controlled for blood transfusion as a confounding factor. 2,3,8 Despite attempts to compare postoperative outcomes between anemic and non-anemic patients, some selection bias may exist. Moreover, there seems to be a lack of data showing longitudinal trends in mortality between anemic and non-anemic patients. This study assessed the immediate outcomes in patients undergoing any type of cardiac surgery and explored the annual mortality trends over an 8-year period in each exposure group. Patients and methods This was an observational, retrospective, matched casecontrol study of prospectively collected data retrieved from our cardiac surgery database (PATS/Dendrite). Patients undergoing elective and urgent cardiac surgery (isolated CABG, isolated valve surgery, combined valve and CABG as well as other complex cardiac surgery) were included. Patients who had emergency procedures were excluded from the analysis because the mortality and morbidity in this group tend to be related to the pathology giving rise to the emergency rather than anemia. This study was approved by the local research authority, and the need for informed consent from the patients was waived. Patients were classified as anemic based on the WHO criteria (preoperative Hb < 13 g dl 1 for males and <12 g dl 1 for females) and matched with a control non-anemic group using the 17 risk factors of the logistic EuroSCORE. These exposure variables include age, sex, chronic obstructive pulmonary disease, extracardiac arteriopathy, neurological dysfunction, previous cardiac surgery, serum creatinine, active endocarditis, critical preoperative state, unstable angina, left ventricular dysfunction, recent myocardial infarction, pulmonary hypertension, urgency of procedure, major cardiac procedure, surgery on the thoracic aorta, and postinfarction septal rupture. Next-neighbor selection (i.e., with the same/similar EuroSCORE) was used to select non-anemic patients for the control group. During the study period ( ), 7150 patients underwent elective and urgent cardiac surgery. There were 1170 patients identified as anemic in the study group; the incidence of preoperative anemia was 16%. A non-anemic matched group of 1170 patients was created from the data-set, using propensity score matching as described above. The patients demographic data and preoperative characteristics are summarized in Table 1. Hospital mortality was defined as death occurring at any time after surgery during the same hospital admission as for the surgery. Prolonged hospital stay was defined as > 7 days after the operation, and immediate blood transfusion referred to the administration of autologous blood within 48 h of surgery. Complex procedures included combined procedures (CABG þ valve surgery, multiple valve surgery, or valve or CABG þ atrial fibrillation ablation) as well as surgery for type A aortic dissection or ischemic ventricular septal defect closure. Surgery > 24 h after admission was categorized as urgent, and surgery within 24 h was classed as an emergency procedure. Our transfusion trigger was set at a hemoglobin level <8gdL 1. We selected a number of outcome variables that were markers of problems related to anemia: hospital mortality; renal replacement therapy; additional airway support such as continuous positive airway pressure, reintubation, or tracheostomy; duration of stay in the cardiac intensive care unit (CICU); prolonged hospital stay; surgical site infection; atrial fibrillation; and costs accrued as a result of number of units of blood transfused and stay both in the CICU and the hospital. Continuous variables are expressed as mean standard deviation or median and interquartile range for Gaussian and skewed distributed data, respectively. Likewise, group comparison was carried out using Student s t test or the Mann-Whitney U test, accordingly. Data expressed as percentages (categorical variables) were analyzed using the chi-square test with the McNemar correction. A value of p was considered to be significant in all statistical tests. The association between preoperative anemia and binary postoperative outcomes was analyzed using logistic regression. The following confounding factors were entered in a multivariable logistic model to assess the relationship between preoperative anemia and outcomes: age, sex, preoperative Hb, preoperative creatinine, diabetes status, logistic EuroSCORE, operative priority, cardiac surgical procedure, cardiopulmonary bypass time, infection (sternal site infection and chest infection), and immediate blood transfusion (<48 h). Statistical analyses were performed using SPSS version 15 software (SPSS, Inc., Chicago, IL, USA). Results Postoperative outcome data in patients with anemia and matched controls without anemia are shown in
3 14 Asian Cardiovascular & Thoracic Annals 24(1) Table 1. Preoperative characteristics of anemic and non-anemic patients undergoing cardiac surgery. Variable Anemic (n ¼ 1170) Non-anemic (n ¼ 1170) p value Age (years) Male 868 (74%) 833 (71%) 0.1 Body mass index (kgm 2 ) Caucasian 942 (81%) 1034 (88%) <0.01 Preoperative hemoglobin (gdl 1 ) <0.01 Preoperative creatinine (mmoll 1 ) <0.01 Logistic EuroSCORE [range] 6.2 [ ] 6.2 [ ] 0.99 Diabetes 748 (64%) 886 (76%) <0.01 Kidney disease 61 (5%) 20 (2%) <0.01 Peripheral vascular disease 271 (23%) 300 (26%) 0.2 Nonsmoker 433 (37%) 468 (40%) 0.3 Chronic obstructive pulmonary disease 196 (17%) 208 (18%) 0.5 Impaired left ventricle 481 (41%) 511 (44%) 0.3 Elective surgery 576 (49%) 621 (53%) 0.06 Procedure 0.03 Isolated coronary artery bypass 624 (53%) 665 (57%) Isolated valve surgery 229 (20%) 181 (16%) Complex/combined surgery 317 (27%) 324 (27%) Table 2. Intra- and postoperative data in anemic and non-anemic patients, including complications and survival. Outcome Anemic (n ¼ 1170) Non-anemic (n ¼ 1170) p value Mortality 65 (5.6%) 41 (3.5%) 0.02 Airway support 171 (15%) 142 (12%) 0.05 Peak postoperative creatinine (mmoll 1 ) <0.01 Renal replacement 150 (13%) 94 (8%) <0.01 Prolonged hospital stay (>7 days) 548 (50%) 473 (42%) 0.08 Surgical site infection 105 (9%) 81 (7%) 0.05 Atrial fibrillation 384 (34%) 403 (35%) 0.6 Median blood transfusion units (48 h) [range] 1 [0 27] 0 [0 23] <0.01 Blood transfusion (overall) 672 (58%) 443 (38%) <0.01 Table 2. The anemic group had a higher percentage requiring renal replacement therapy (13% vs. 8%, p < 0.01), increased need for airway support (15% vs. 12%, p ¼ 0.05), and an increased rate of surgical site infection (9% vs. 7%, p ¼ 0.05) compared to the nonanemic group. Overall, the anemic group required an additional 1392 days in CICU (5419 vs days, p < 0.01). Likewise, the additional hospital stay was 2275 days (13271 vs days, p < 0.01). The proportion of patients needing immediate blood transfusion (within 48 hours) (54% vs. 33.2%, p < 0.01) and the number of units transfused in the anemia group (2314 vs. 1254, p < 0.01) were significantly higher than in the non-anemic group. After controlling for risk factors (age, sex, preoperative Hb, preoperative creatinine, diabetes status, logistic EuroSCORE, operative priority, cardiac surgical procedure, cardiopulmonary bypass time, infection, and immediate blood transfusion), multivariate regression demonstrated that preoperative anemia was independently associated with renal replacement therapy (odds ratio ¼ 1.76, confidence interval: , p ¼ 0.002) and prolonged (>7 days) hospital stay (odds ratio ¼ 1.21, confidence interval: , p ¼ 0.08). Hospital mortality was higher in anemic patients (5.6% vs. 3.5%, p ¼ 0.02) and over the study period, mortality in the nonanemic group dropped from 6.5% in the year to 1.6% in the year (p < 0.01), without a significant change in the logistic EuroSCORE between these two periods. In the anemic group, the
4 Padmanabhan et al. 15 Figure 1. Mortality in anemic and non-anemic patient groups in various eras (p < 0.01) Logistic EuroSCORE (mortality risk predictor) and actual mortality in the two groups over the last 8 years showed significant improvement in mortality in the non-anemic group (6.5% in to 1.6% in ) compared to the anemic group (6.7% in to 4.7% in ). improvement was much less over the same period, changing from 6.7% in the year to 4.7% in the year (Figure 1). Discussion This study demonstrates that patients with anemia had more adverse outcomes than matched non-anemic patients. The higher hospital mortality seen in the anemic group is consistent with previous reports. 1,3,4,8 Ranucci and colleagues 8 found that mortality was higher in patients with severe anemia compared to controls (12.7% vs. 7.5%, p ¼ 0.01). van Straten and colleagues 3 found that early (10.3% vs. 3.5%, p < ) and late mortality (43.8% vs. 18.1%, p < 0.001) was considerably higher in patients with preoperative anemia. Our study also demonstrates that the degree of improvement in mortality seen in the non-anemic group over the last 7 years was not replicated in anemic patients. There was a previous observational study in our unit, analyzing the effect of man-power and team-working on improvement in mortality over the last 10 years. 10 Given that both the anemic and non-anemic groups were managed by the same teams, the difference in degree of mortality improvement between the two groups was most likely due to the presence of anemia. Moreover, our data demonstrating an association between anemia and other outcome measures of resource utilization agree with studies in which there may have been some restriction in patient selection. In our study, multivariate regression showed that preoperative anemia was an independent predictor of acute kidney injury leading to renal replacement therapy (odds ratio ¼ 1.76, confidence interval: , p ¼ 0.002) and a prolonged (>7 days) in-hospital duration of stay (odds ratio ¼ 1.21, confidence interval: , p ¼ 0.08). De Santo and colleagues 6 found that preoperative anemia (based on the WHO definition) was independently associated with acute kidney injury and hospital stay > 7 days. In a study by Kulier and colleagues, 5 patients with a hematocrit < 36% had a longer intensive care unit stay compared to nonanemic patients. A significant association between anemia and prolonged intensive care unit stay was also reported by Hung and colleagues. 1 Our study also showed that patients with and without anemia differ in the need for airway support (15% vs. 12%, p ¼ 0.05). Anemic patients were found to have a higher incidence of infection, particularly surgical site infection (9% vs. 7%, p ¼ 0.05) compared to the nonanemic group. Likewise, in a recent study by Ranucci and colleagues, 8 the duration of mechanical ventilation was longer and the incidence of blood stream infection was higher in severely anemic patients (hematocrit < 30%). The cause of the deleterious effect of preoperative anemia on outcomes is multifactorial. First, anemic patients consume a substantially higher amount of blood products. Although blood transfusion is given in an effort to enhance oxygen delivery and improve outcomes, yet in susceptible patients, it may impair tissue oxygen delivery, leading to organ dysfunction. Blood transfusion can generate a systemic inflammatory response secondary to an altered host-immune response. 11 Depletion of 2,3-diphosphoglycerate levels and morphological changes in red cells due to depletion of adenosine triphosphate can severely limit oxygen delivery to the tissues Second, anemic patients have a much high prevalence of comorbidities such as diabetes and kidney disease, which can put them at higher risk. Third, there is evidence linking
5 16 Asian Cardiovascular & Thoracic Annals 24(1) preoperative anemia and hemodilution during cardiopulmonary bypass with adverse outcomes. This can lead to tissue hypoxia and an increased likelihood of postoperative renal injury Given this evidence of the detrimental effects of preoperative anemia, its correction before surgery is vital. Our current strategy of restoring normal Hb levels with allogeneic blood transfusion in the immediate perioperative period is not only associated with adverse outcomes but also an economic and resource burden on transfusion services The cost to the National Health Service for blood transfusion is 110 GBP for one unit of blood. However, the cumulative service cost for providing blood transfusion is considerably higher than this single unit. Patients with preoperative anemia had increased CICU and hospital stays of 1392 days and 2275 days, respectively, compared to the nonanemic group. The cost of one day in the CICU is 1200 GBP, and one day in the ward is 385 GBP. One can extrapolate that there is significant additional cost associated with managing an anemic patient compared to a non-anemic one. Without taking into account the cost of treating infections, renal replacement therapy, reexplorations, and additional airway support, the additional cost for treating the anemic group was at least 2.3 million GBP. Alternative strategies to treat anemia include erythropoietin supplementation and oral or intravenous iron before surgery. Two randomized trials of anemic patients undergoing cardiac surgery have demonstrated the efficacy of preoperative recombinant human erythropoietin administration to decrease blood transfusions. 22,23 A recent study has shown that administration of intravenous iron for preoperative anemia in patients with colorectal cancer was associated with an increase in Hb and a reduction in allogenic blood transfusions. Cladellas and colleagues 24 have shown that combined therapy with intravenous recombinant human erythropoietin and intravenous iron administered before cardiac valve replacement in anemic patients was associated with an improvement in postoperative outcomes and a decrease in blood transfusions. Although these treatment options appear attractive, further studies are required to evaluate their usage in the context of cardiac surgery. This study had some limitations. First, it was a retrospective study that relied on the completeness or accuracy of recorded information. Second, despite the utility of our findings and applicability to a broad patient group with even mild anemia, our data were observational and may still be prone to confounding factors. Owing to the limitations of our study design, it is possible that there was a selection bias and unknown confounding factors for which there were insufficient statistical adjustments. Random allocation of treatment would eliminate selection bias and confounding factors. To determine the benefit of preoperative treatment options (oral iron, intravenous iron, or erythropoietin) for correcting preoperative anemia, randomized controlled trials would be desirable. If intravenous iron therapy is proven to improve the preoperative Hb level, then the need for blood transfusion is likely to be reduced. Additional effects such as preoperative optimization will be in line with the government strategy to enhance recovery after surgery. Our results agree with previous studies, but we have integrated the gaps in the literature by using wider selection criteria to include mildly anemic patients, based on the WHO definition, including patients undergoing isolated CABG or complex valve surgery with or without CABG, and adjusting for a greater number of confounding factors including blood transfusion. Over all, anemic patients experience worse outcomes and potentially consume significantly more resources during their cardiac surgical stay. Although mortality has improved significantly over the last decade, the degree is less in anemic patients, and further improvements are likely to be possible by treating the underlying condition and implementing preoperative therapies. Presented at FACTS-Care 2013, 10th Annual CVT Critical Care Conference, Washington, USA, October 10 12, Declaration of conflicting interests The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. Funding The authors received no financial support for the research, authorship, and/or publication of this article. References 1. Hung M, Besser M, Sharples LD, Nair SK and Klein AA. The prevalence and association with transfusion, intensive care unit stay and mortality of pre-operative anaemia in a cohort of cardiac surgery patients. Anaesthesia 2011; 66: Zindrou D, Taylor KM and Bagger JP. Preoperative haemoglobin concentration and mortality rate after coronary artery bypass surgery. Lancet 2002; 359: van Straten AH, Hamad MA, van Zundert AJ, Martens EJ, Schonberger JP and de Wolf AM. Preoperative hemoglobin level as a predictor of survival after coronary artery bypass grafting: a comparison with the matched general population. Circulation 2009; 120: Karkouti K, Wijeysundera DN and Beattie WS Reducing Bleeding in Cardiac Surgery (RBC) Investigators. Risk associated with preoperative anemia in cardiac surgery: a multicenter cohort study. Circulation 2008; 117:
6 Padmanabhan et al Kulier A, Levin J, Moser R, et al. Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery. Circulation 2007; 116: De Santo L, Romano G, Della Corte A, et al. Preoperative anemia in patients undergoing coronary artery bypass grafting predicts acute kidney injury. J Thorac Cardiovasc Surg 2009; 138: Boening A, Boedeker RH, Scheibelhut C, Rietzschel J, Roth P and Schonburg M. Anemia before coronary artery bypass surgery as additional risk factor increases the perioperative risk. Ann Thorac Surg 2011; 92: Ranucci M, Di Dedda U, Castelvecchio S, Menicanti L, Frigiola A and Pelissero G. Impact of preoperative anemia on outcome in adult cardiac surgery: a propensity-matched analysis. Ann Thorac Surg 2012; 94: Nutritional anaemia. Report of a WHO Scientific Group. World Health Organization Technical Report Series 1968; 405: Southey D, Mishra PK, Nevill A, Aktuerk D and Luckraz H. Continuity of care by cardiothoracic nurse practitioners: Impact on outcome. Asian Cardiovasc Thorac Ann 2014; 22: Tinmouth A, Fergusson D, Yee IC and Hebert PC. Clinical consequences of red cell storage in the critically ill. Transfusion 2006; 46: Valtis DJ. Defective gas-transport function of stored red blood-cells. Lancet 1954; 266: Valeri CR and Hirsch NM. Restoration in vivo of erythrocyte adenosine triphosphate, 2,3-diphosphoglycerate, potassium ion, and sodium ion concentrations following the transfusion of acid-citrate-dextrose-stored human red blood cells. J Lab Clin Med 1969; 73: Dern RJ, Brewer GJ and Wiorkowski JJ. Studies on the preservation of human blood. II. The relationship of erythrocyte adenosine triphosphate levels and other in vitro measures to red cell storageability. J Lab Clin Med 1967; 69: DeFoe GR, Ross CS, Olmstead EM, et al. Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group. Ann Thorac Surg 2001; 71: Swaminathan M, Phillips-Bute BG, Conlon PJ, Smith PK, Newman MF and Stafford-Smith M. The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary artery bypass surgery. Ann Thorac Surg 2003; 76: Karkouti K, Beattie WS, Wijeysundera DN, et al. Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery. J Thorac Cardiovasc Surg 2005; 129: Surgenor SD, Kramer RS, Olmstead EM, et al. The association of perioperative red blood cell transfusions and decreased long-term survival after cardiac surgery. Anesth Analg 2009; 108: Ranucci M, Baryshnikova E, Castelvecchio S and Pelissero G. Major bleeding, transfusions, and anemia: the deadly triad of cardiac surgery. Ann Thorac Surg 2013; 96: Koch CG, Li L, Duncan AI, et al. Morbidity and mortality risk associated with red blood cell and bloodcomponent transfusion in isolated coronary artery bypass grafting. Crit Care Med 2006; 34: van Straten AH, Bekker MW, Soliman Hamad MA, et al. Transfusion of red blood cells: the impact on short-term and long-term survival after coronary artery bypass grafting, a ten-year follow-up. Interact Cardiovasc Thorac Surg 2010; 10: Sowade O, Warnke H, Scigalla P, et al. Avoidance of allogeneic blood transfusions by treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing open-heart surgery. Blood 1997; 89: Kiyama H, Ohshima N, Imazeki T and Yamada T. Autologous blood donation with recombinant human erythropoietin in anemic patients. Ann Thorac Surg 1999; 68: Cladellas M, Farre N, Comin-Colet J, et al. Effects of preoperative intravenous erythropoietin plus iron on outcome in anemic patients after cardiac valve replacement. Am J Cardiol 2012; 110:
12 RANUCCI ET AL Ann Thorac Surg HEMODILUTION DURING CPB AND MORBIDITY RISK 2010;89:11 8 Abbreviations and Acronyms CI confidence interval CPB cardiop
ORIGINAL ARTICLES: CARDIOTHORACIC ANESTHESIOLOGY: The Annals of Thoracic Surgery CME Program is located online at http://cme.ctsnetjournals.org. To take the CME activity related to this article, you must
More informationTransfusion & Mortality. Philippe Van der Linden MD, PhD
Transfusion & Mortality Philippe Van der Linden MD, PhD Conflict of Interest Disclosure In the past 5 years, I have received honoraria or travel support for consulting or lecturing from the following companies:
More informationTransfusion and Blood Conservation
Transfusion and Blood Conservation Kenneth G. Shann, CCP Assistant Director, Perfusion Services Senior Advisor, Performance Improvement Department of Cardiovascular and Thoracic Surgery Montefiore Medical
More informationPreoperative anemia is an independent predictor
Original Article EFFECT OF PREOPERATIVE ANEMIA ON OUTCOME AFTER CARDIAC SURGERY Saba Riaz a*, Imran khan a, Saira Gul a, Madiha Iqbal a, Shumaila Afshan a, Abdul Waheed a ABSTRACT: OBJECTIVE: Good anemic
More informationFEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery
EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2010 FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery Nicholas L Mills, David A McAllister, Sarah Wild, John D MacLay,
More informationPreoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery?
Preoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery? Damien J. LaPar MD, MSc, James M. Isbell MD, MSCI, Jeffrey B. Rich MD, Alan M. Speir MD, Mohammed
More informationPreoperative anemia Common, consequential and correctable in non-emergent surgery By Kathrine Frey, MD
Preoperative anemia Common, consequential and correctable in non-emergent surgery By Kathrine Frey, MD Preoperative anemia is common, especially in patients undergoing nonemergent high-blood-loss surgical
More informationCardiovascular Surgery
Cardiovascular Surgery Preoperative Hemoglobin Level as a Predictor of Survival After Coronary Artery Bypass Grafting A Comparison With the Matched General Population Albert H.M. van Straten, MD; Mohamed
More informationSetting The setting was a hospital. The economic study was carried out in Australia.
Coronary artery bypass grafting (CABG) after initially successful percutaneous transluminal coronary angioplasty (PTCA): a review of 17 years experience Barakate M S, Hemli J M, Hughes C F, Bannon P G,
More informationPreparing for Patients at High Risk of Transfusion
18/10/2017 Preparing for Patients at High Risk of Transfusion Jane Ottens. B.Sc., CCP ( Aust) Ashford Hospital, South Australia Preparing for Patients at High Risk of Transfusion Jane Ottens. B.Sc., CCP
More informationIntraoperative application of Cytosorb in cardiac surgery
Intraoperative application of Cytosorb in cardiac surgery Dr. Carolyn Weber Heart Center of the University of Cologne Dept. of Cardiothoracic Surgery Cologne, Germany SIRS & Cardiopulmonary Bypass (CPB)
More informationKing s Research Portal
King s Research Portal DOI: 10.1053/j.jvca.2016.02.004 Document Version Peer reviewed version Link to publication record in King's Research Portal Citation for published version (APA): Hallward, G., Balani,
More informationRisk Factors and Management of Acute Renal Injury in Cardiac Surgery
Risk Factors and Management of Acute Renal Injury in Cardiac Surgery Robert S Kramer, MD, FACS Clinical Associate Professor of Surgery Tufts University School of Medicine Maine Medical Center, Portland
More informationPredictive models for kidney disease: improving global outcomes (KDIGO) defined acute kidney injury in UK cardiac surgery
Birnie et al. Critical Care 2014, 18:606 RESEARCH Open Access Predictive models for kidney disease: improving global outcomes (KDIGO) defined acute kidney injury in UK cardiac surgery Kate Birnie 1, Veerle
More informationPreoperative anemia increases mortality and postoperative morbidity after cardiac surgery
Miceli et al. Journal of Cardiothoracic Surgery 2014, 9:137 RESEARCH ARTICLE Open Access Preoperative anemia increases mortality and postoperative morbidity after cardiac surgery Antonio Miceli 1,2, Francesco
More informationAdvances in Transfusion and Blood Conservation
Advances in Transfusion and Blood Conservation Arman Kilic, MD Division of Cardiac Surgery, Department of Surgery, Johns Hopkins Hospital, Baltimore, MD No relevant financial relationships to disclose.
More informationA Validated Practical Risk Score to Predict the Need for RVAD after Continuous-flow LVAD
A Validated Practical Risk Score to Predict the Need for RVAD after Continuous-flow LVAD SK Singh MD MSc, DK Pujara MBBS, J Anand MD, WE Cohn MD, OH Frazier MD, HR Mallidi MD Division of Transplant & Assist
More informationTransfusion and Blood Stream Infections after Coronary Surgery
1 Transfusion and Blood Stream Infections after Coronary Surgery Tuomas Tauriainen, a Eeva-Maija Kinnunen, a Idamaria Laitinen, a Vesa Anttila, b Tuomas Kiviniemi, b Juhani K.E. Airaksinen, b and Fausto
More informationPreoperative tests (update)
National Institute for Health and Care Excellence. Preoperative tests (update) Routine preoperative tests for elective surgery NICE guideline NG45 Appendix C: April 2016 Developed by the National Guideline
More informationRespiratory failure (RF), or prolonged mechanical ventilation,
CARDIOTHORACIC ANESTHESIOLOGY: The Annals of Thoracic Surgery CME Program is located online at http://cme.ctsnetjournals.org. To take the CME activity related to this article, you must have either an STS
More informationManaging Hypertension in the Perioperative Arena
Managing Hypertension in the Perioperative Arena Optimizing Perioperative Management Strategies for Hypertension in the Cardiac Surgical Patient Objectives: Treatment of hypertensive emergencies. ALBERT
More informationTEG-Directed Transfusion in Complex Cardiac Surgery: Impact on Blood Product Usage
TEG-Directed Transfusion in Complex Cardiac Surgery: Impact on Blood Product Usage Kevin Fleming, CCP; Roberta E. Redfern, PhD; Rebekah L. March, MPH; Nathan Bobulski, CCP; Michael Kuehne, PhD, PA-C; John
More informationThe Relationship between Intra-Operative Transfusions and Nadir Hematocrit on Post-Operative Outcomes after Cardiac Surgery
The Journal of ExtraCorporeal Technology The Relationship between Intra-Operative Transfusions and Nadir Hematocrit on Post-Operative Outcomes after Cardiac Surgery Joshua B. Goldberg, MD;* Kenneth G.
More informationDoes Preoperative Hemoglobin Independently Predict Short-Term Outcomes After Coronary Artery Bypass Graft Surgery?
CARDIOTHORACIC ANESTHESIOLOGY: The Annals of Thoracic Surgery CME Program is located online at http://cme.ctsnetjournals.org. To take the CME activity related to this article, you must have either an STS
More informationUniversity of Bristol - Explore Bristol Research
Rogers, C., Capoun, R., Scott, L., Taylor, J., Angelini, G., Narayan, P.,... Ascione, R. (2017). Shortening cardioplegic arrest time in patients undergoing combined coronary and valve surgery: results
More informationPreoperative Serum Bicarbonate Levels Predict Acute Kidney Iinjry after Cardiac Surgery
International Journal of ChemTech Research CODEN (USA): IJCRGG, ISSN: 0974-4290, ISSN(Online):2455-9555 Vol.11 No.06, pp 203-208, 2018 Preoperative Serum Bicarbonate Levels Predict Acute Kidney Iinjry
More informationDefining Optimal Perfusion during CPB. Carlo Alberto Tassi Marketing Manager Eurosets Italy
Defining Optimal Perfusion during CPB Carlo Alberto Tassi Marketing Manager Eurosets Italy It is a device able to monitor in a real time vital parameters and able to provide information regarding the transport
More informationCost-effectiveness of minimally invasive coronary artery bypass surgery Arom K V, Emery R W, Flavin T F, Petersen R J
Cost-effectiveness of minimally invasive coronary artery bypass surgery Arom K V, Emery R W, Flavin T F, Petersen R J Record Status This is a critical abstract of an economic evaluation that meets the
More informationAcute Kidney Injury after Cardiac Surgery: Incidence, Risk Factors and Prevention
Acute Kidney Injury after Cardiac Surgery: Incidence, Risk Factors and Prevention Hong Liu, MD Professor of Clinical Anesthesiology Department of Anesthesiology and Pain Medicine University of California
More informationPatient Blood Management: Enough is Enough
Patient Blood Management: Enough is Enough Richard Benjamin, MBChB, PhD, FRCPath Professor of Pathology Georgetown University Medical Center Washington, D.C. Chief Medical Officer Cerus Corporation Concord,
More informationA case-control study of readmission to the intensive care unit after cardiac surgery
DOI: 0.2659/MSM.88384 Received: 202.04.24 Accepted: 203.0.25 Published: 203.02.28 A case-control study of readmission to the intensive care unit after cardiac surgery Authors Contribution: Study Design
More informationPREDICTORS OF PROLONGED HOSPITAL STAY
PREDICTORS OF PROLONGED HOSPITAL STAY IN CARDIAC SURGERY Zuraida Khairudin Faculty of Science Computer and Mathematics, Universiti Teknologi MARA, Malaysia zurai405@salam.uitm.edu.my ABSTRACT quality of
More informationEACTS Adult Cardiac Database
EACTS Adult Cardiac Database Quality Improvement Programme List of changes to Version 2.0, 13 th Dec 2018, compared to version 1.0, 1 st May 2014. INTRODUCTORY NOTES This document s purpose is to list
More informationPreoperative tests (update)
National Institute for Health and Care Excellence. Preoperative tests (update) Routine preoperative tests for elective surgery NICE guideline NG45 Appendix N: Research recommendations April 2016 Developed
More informationAnemia Management: Using Epo and Iron
Anemia Management: Using Epo and Iron Ky Stoltzfus, MD University of Kansas Medical Center Assistant Professor Department of Internal Medicine January 23, 2013 Regulation of red cell production Treatment
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL Table S1: Number and percentage of patients by age category Distribution of age Age
More informationAge of transfused blood is not associated with increased postoperative adverse outcome after cardiac surgery
British Journal of Anaesthesia 106 (5): 643 9 (2011) Advance Access publication 16 March 2011. doi:10.1093/bja/aer029 CARDIOVASCULAR Age of transfused blood is not associated with increased postoperative
More informationA Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery
A Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery Arman Kilic, MD 1, Rika Ohkuma, MD 1, J. Trent Magruder, MD 1, Joshua C. Grimm, MD 1, Marc Sussman, MD 1, Eric B. Schneider, PhD 1,
More informationEffect of Body Mass Index on Early Outcomes in Patients Undergoing Coronary Artery Bypass Surgery
Journal of the American College of Cardiology Vol. 42, No. 4, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0735-1097(03)00777-0
More informationPredictive Model for Blood Product Use in Coronary Artery Bypass Grafting
ORIGINAL ARTICLE Predictive Model for Blood Product Use in Coronary Artery Bypass Grafting Hasanat Sharif, Hamza Zaheer Ansari, Awais Ashfaq, Wasiq Faraz Rawasia, Gulshan Bano and Shiraz Hashmi ABSTRACT
More informationOn-Pump vs. Off-Pump CABG: The Controversy Continues. Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery
On-Pump vs. Off-Pump CABG: The Controversy Continues Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery On-pump vs. Off-Pump CABG: The Controversy Continues Conflict
More informationDoes the Use of Ultrafiltration Increase the Risk of Post-Operative Acute Kidney Injury? A Multi-Center Analysis
Does the Use of Ultrafiltration Increase the Risk of Post-Operative Acute Kidney Injury? A Multi-Center Analysis Gordon R. DeFoe, CCP, John Pieroni, CCP, Craig S. Warren, CCP, Charles F. Krumholz, CCP,
More informationSupplementary Online Content. Mozaffarian D, Marchioli R, Macchia A, et al; for the OPERA Investigators. Fish oil and
Supplementary Online Content Mozaffarian D, Marchioli R, Macchia A, et al; for the OPERA Investigators. Fish oil and postoperative atrial fibrillation: The Omega-3 Fatty Acids for Prevention of POst-operative
More informationIMPROVE PATIENT OUTCOMES AND SAFETY IN ADULT CARDIAC SURGERY.
Clinical Evidence Guide IMPROVE PATIENT OUTCOMES AND SAFETY IN ADULT CARDIAC SURGERY. With the INVOS cerebral/somatic oximeter An examination of controlled studies reveals that responding to cerebral desaturation
More informationTrend and Outcomes of Direct Transcatheter Aortic Valve Replacement from a Single-Center Experience
Cardiol Ther (2018) 7:191 196 https://doi.org/10.1007/s40119-018-0115-0 BRIEF REPORT Trend and Outcomes of Direct Transcatheter Aortic Valve Replacement from a Single-Center Experience Anthony A. Bavry.
More informationIschemic Ventricular Septal Rupture
Ischemic Ventricular Septal Rupture Optimal Management Strategies Juan P. Umaña, M.D. Chief Medical Officer FCI Institute of Cardiology Disclosures Abbott Mitraclip Royalties Johnson & Johnson Proctor
More informationDoes Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?
Original Article Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Hiroaki Sakamoto, MD, PhD, and Yasunori Watanabe, MD, PhD Background: Recently, some articles
More informationChairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine
Leonard N. Girardi, M.D. Chairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine New York, New York Houston Aortic Symposium Houston, Texas February 23, 2017 weill.cornell.edu
More informationIndications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014
Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such
More informationDepartment of Hematology, Sultan Qaboos University Hospital, Muscat, Oman 2. Department of Surgery, Sultan Qaboos University Hospital, Muscat, Oman 3
original article Oman Medical Journal [2019], Vol. 34, No. 1: 14-19 Impact of Blood Transfusion on Troponin I Levels and Outcomes after Cardiac Surgery: A Cohort Study Arwa Z. Al-Riyami 1, Murtadha Al-Khabori
More informationPeri-Surgical Anemia and the TAVR Patient
Peri-Surgical Anemia and the TAVR Patient Kathrine P Frey, MD Fairview Southdale Hospital Director of Blood and Pre-Operative Anemia Management April, 2015 MIDWEST VALVE SYMPOSIUM, April 2015 Credentials
More informationCommon Codes for ICD-10
Common Codes for ICD-10 Specialty: Cardiology *Always utilize more specific codes first. ABNORMALITIES OF HEART RHYTHM ICD-9-CM Codes: 427.81, 427.89, 785.0, 785.1, 785.3 R00.0 Tachycardia, unspecified
More informationInstitute of Medical Epidemiology, Biostatistics, and Informatics, University of Halle-Wittenberg, Halle (Saale) 2
Do Randomized and Non-Randomized Trials Yield Different Answers in Similar Populations? Evidence from a 'Meta-Propensity Score' Analysis in Cardiac Surgery Kuss O 1, Legler T 1, Börgermann J 2 1 Institute
More informationCORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW
CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS F MEASURES GROUPS: 2015 PQRS MEASURES IN CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP: #43 Coronary Artery Bypass Graft (CABG):
More informationClinical Impact of Red-Cell Storage Lesion A Survey and Possible Consequences
Clinical Impact of Red-Cell Storage Lesion A Survey and Possible Consequences Behrouz Mansouri Taleghani Center of Transfusion Medicine Bern Department of Hematology and Central Hematological Laboratory
More informationAssessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington
Assessing Cardiac Risk in Noncardiac Surgery Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington Disclosure None. I have no conflicts of interest, financial or otherwise. CME
More informationBicuspid aortic root spared during ascending aorta surgery: an update of long-term results
Short Communication Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Marco Russo, Guglielmo Saitto, Paolo Nardi, Fabio Bertoldo, Carlo Bassano, Antonio Scafuri,
More informationContemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology
Contemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology Damien J. LaPar, MD, MSc, Daniel P. Mulloy, MD, Ivan K. Crosby, MBBS, D. Scott Lim, MD,
More informationTransfusion triggers in acute coronary syndromes: The MINT trial
Transfusion triggers in acute coronary syndromes: The MINT trial Paul Hébert, MD MHSc(Epid) Physician-in-Chief, CHUM Professor, University of Montreal Objectives Review evidence on transfusion triggers
More informationBlood transfusions in ICU: double-edged sword. Paul Hébert, MD MHSc(Epid) Physician-in-Chief, CHUM Professor, University of Montreal
Blood transfusions in ICU: double-edged sword Paul Hébert, MD MHSc(Epid) Physician-in-Chief, CHUM Professor, University of Montreal Canadian Critical Care Trials Group Collaborating for Impact Leading
More informationPOSTOPERATIVE HEMORRHAGE in cardiac surgery is a
Increased Chest Tube Drainage Is Independently Associated With Adverse Outcome After Cardiac Surgery Michael C. Christensen, MSc, MPA, DrPH,* Frank Dziewior, MD, Angela Kempel, MSc, and Christian von Heymann,
More informationInstitute of Medical Epidemiology, Biostatistics, and Informatics, University of Halle-Wittenberg, Halle (Saale) 2
Do Randomized and Non-Randomized Trials Yield Different Answers in Similar Populations? Evidence from a 'Meta-Propensity Score' Analysis in Cardiac Surgery Kuss O 1, Legler T 1, Börgermann J 2 1 Institute
More informationCardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition
Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Table of Contents Volume 1 Chapter 1: Cardiovascular Anatomy and Physiology Basic Cardiac
More informationSurgical Outcomes: A synopsis & commentary on the Cardiac Care Quality Indicators Report. May 2018
Surgical Outcomes: A synopsis & commentary on the Cardiac Care Quality Indicators Report May 2018 Prepared by the Canadian Cardiovascular Society (CCS)/Canadian Society of Cardiac Surgeons (CSCS) Cardiac
More informationSupplementary Online Content
1 Supplementary Online Content Friedman DJ, Piccini JP, Wang T, et al. Association between left atrial appendage occlusion and readmission for thromboembolism among patients with atrial fibrillation undergoing
More informationCopyright by ICR Publishers 2005
Does EuroSCORE Predict Length of Stay and Specific Postoperative Complications after Heart Valve Surgery? Ioannis K. Toumpoulis 1,2, Constantine E. Anagnostopoulos 1,2 1 Columbia University College of
More informationAge and blood transfusion: relationship and prognostic implications in cardiac surgery
Original Article Age and blood transfusion: relationship and prognostic implications in cardiac surgery Luca Salvatore De Santo 1,2, Gianpaolo Romano 3, Emilio Mango 2, Francesco Iorio 2, Leonardo Savarese
More informationPredicting Short Term Morbidity following Revision Hip and Knee Arthroplasty
Predicting Short Term Morbidity following Revision Hip and Knee Arthroplasty A Review of ACS-NSQIP 2006-2012 Arjun Sebastian, M.D., Stephanie Polites, M.D., Kristine Thomsen, B.S., Elizabeth Habermann,
More informationManagement of a Patient after the Bidirectional Glenn
Management of a Patient after the Bidirectional Glenn Melissa B. Jones MSN, APRN, CPNP-AC CICU Nurse Practitioner Children s National Health System Washington, DC No Disclosures Objectives qbriefly describe
More informationThe incidence and risk factors of arrhythmias in the early period after cardiac surgery in pediatric patients
The Turkish Journal of Pediatrics 2008; 50: 549-553 Original The incidence and risk factors of arrhythmias in the early period after cardiac surgery in pediatric patients Selman Vefa Yıldırım 1, Kürşad
More informationPre-operative anaemia is associated with total morbidity burden on days 3 and 5 after cardiac surgery: a cohort study
Sanders et al. Perioperative Medicine (2017) 6:1 DOI 10.1186/s13741-017-0057-4 RESEARCH Open Access Pre-operative anaemia is associated with total morbidity burden on days 3 and 5 after cardiac surgery:
More informationEmergency surgery in acute coronary syndrome
Emergency surgery in acute coronary syndrome Teerawoot Jantarawan Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
More informationUseful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication vs Benefit? Mortality? Morbidity?
Preoperative intraaortic balloon counterpulsation in high-risk CABG Stefan Klotz, M.D. Preoperative IABP in high-risk CABG Questions?? Useful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication
More informationPostoperative stroke after off-pump versus on-pump coronary artery bypass surgery
Postoperative stroke after off-pump versus on-pump coronary artery bypass surgery Fausto Biancari, MD, PhD, Martti Mosorin, MD, Elsi Rasinaho, MS, Jarmo Lahtinen, MD, Jouni Heikkinen, MD, Eija Niemelä,
More informationEdgar Hernández-Leiva 1*, Rodolfo Dennis 2, Daniel Isaza 3 and Juan Pablo Umaña 4
Hernández-Leiva et al. Journal of Cardiothoracic Surgery 2013, 8:170 RESEARCH ARTICLE Open Access Hemoglobin and B-type natriuretic peptide preoperative values but not inflammatory markers, are associated
More informationIncidence of Postoperative Atrial Fibrillation after minimally invasive mitral valve surgery
Incidence of Postoperative Atrial Fibrillation after minimally invasive mitral valve surgery JUAN S. JARAMILLO, MD Cardiovascular Surgery Clinica CardioVID Medellin Colombia DISCLOSURE INFORMATION Consultant
More informationHeinz-Hermann Weitkemper, EBCP. 4th Joint Scandinavian Conference in Cardiothoracic Surgery 2012 Vilnius / Lithuania
Heinz-Hermann Weitkemper, EBCP Everyone who earnestly practices perfusion is acting with the full belief that what they are doing is in the best interest of their patients. Perfusion can never be normal,
More informationAtrial Fibrillation Correction Surgery: Lessons From The Society of Thoracic Surgeons National Cardiac Database
Atrial Fibrillation Correction Surgery: Lessons From The Society of Thoracic Surgeons National Cardiac Database James S. Gammie, MD, Michel Haddad, MD, Sarah Milford-Beland, MS, Karl F. Welke, MD, T. Bruce
More informationEVIDENCE BASED RED CELL TRANSFUSION. Rana Samuel, MD DIRECTOR, PATHOLOGY AND LABORATORY MEDICINE VA WNY Health Care System
EVIDENCE BASED RED CELL TRANSFUSION Rana Samuel, MD DIRECTOR, PATHOLOGY AND LABORATORY MEDICINE VA WNY Health Care System HISTORY Blood transfusion works (ie: red cell transfusion saves lives). based on
More informationTSDA ACGME Milestones
TSDA ACGME Milestones Short MW and Edwards JA. Assessing resident milestones using a CASPE March 2012 Short MW and Edwards JA. Assessing resident milestones using a CASPE March 2012 Short
More informationRandomized comparison of single versus double mammary coronary artery bypass grafting: 5 year outcomes of the Arterial Revascularization Trial
Randomized comparison of single versus double mammary coronary artery bypass grafting: 5 year outcomes of the Arterial Revascularization Trial Embargoed until 10:45 a.m. CT, Monday, Nov. 14, 2016 David
More informationEffectiveness and efficiency of pre-operative anaemia management with intravenous iron: A systematic review
Effectiveness and efficiency of pre-operative anaemia management with intravenous iron: A systematic review Bernd Froessler MD, FANZCA 1,2, MSc Clinical Sciences Candidate Contact: bernd.froessler@health.sa.gov.au
More informationSurgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea
Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea Contents Decision making in surgical AVR in old age Clinical results of AVR with tissue valve Impact of 19mm
More informationImportance of the third arterial graft in multiple arterial grafting strategies
Research Highlight Importance of the third arterial graft in multiple arterial grafting strategies David Glineur Department of Cardiovascular Surgery, Cliniques St Luc, Bouge and the Department of Cardiovascular
More informationMAKING THE NSQIP PARTICIPANT USE DATA FILE (PUF) WORK FOR YOU
MAKING THE NSQIP PARTICIPANT USE DATA FILE (PUF) WORK FOR YOU Hani Tamim, PhD Clinical Research Institute Department of Internal Medicine American University of Beirut Medical Center Beirut - Lebanon Participant
More informationGoal Directed Therapy : Liberal vs Restrictive Transfusion.. Syafri Kamsul Arif
Goal Directed Therapy : Liberal vs Restrictive Transfusion. Syafri Kamsul Arif Sepsis Perioperative EGDT PGDT PGDT Protocol Stroke volume optimization with fluid protocol SVV or PPV based GDT Protocol
More informationObesity and early complications after cardiac surgery
Obesity and early complications after cardiac surgery Cheng-Hon Yap, Morteza Mohajeri and Michael Yii Despite heightened public awareness that obesity is a major risk factor for cardiac disease and death,
More informationEuroSCORE Predicts Short- and Mid-Term Mortality in Combined Aortic Valve Replacement and Coronary Artery Bypass Patients
c 2009 Wiley Periodicals, Inc. 637 EuroSCORE Predicts Short- and Mid-Term Mortality in Combined Aortic Valve Replacement and Coronary Artery Bypass Patients Kimiyoshi J. Kobayashi, B.S., Jason A. Williams,
More informationCoronary Artery Bypass Graft: Monitoring Patients and Detecting Complications
Coronary Artery Bypass Graft: Monitoring Patients and Detecting Complications Madhav Swaminathan, MD, FASE Professor of Anesthesiology Division of Cardiothoracic Anesthesia & Critical Care Duke University
More informationSurgical AF Ablation : Lesion Sets and Energy Sources. What are the data? Steven F Bolling, MD Cardiac Surgery University of Michigan
Surgical AF Ablation : Lesion Sets and Energy Sources What are the data? Steven F Bolling, MD Cardiac Surgery University of Michigan Disclosures Consultant/Advisory Board: Abbott, Edwards Lifesciences
More informationValve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal
Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal I have nothing to disclose. Wide Spectrum Stable vs Decompensated NYHA II IV? Ejection
More informationSupplementary Online Content
Supplementary Online Content Inohara T, Manandhar P, Kosinski A, et al. Association of renin-angiotensin inhibitor treatment with mortality and heart failure readmission in patients with transcatheter
More informationRemodeling of the Remnant Aorta after Acute Type A Aortic Dissection Surgery
Remodeling of the Remnant Aorta after Acute Type A Aortic Dissection Surgery Are Young Patients More Likely to Develop Adverse Aortic Remodeling of the Remnant Aorta Over Time? Suk Jung Choo¹, Jihoon Kim¹,
More informationMajor Infection After Pediatric Cardiac Surgery: External Validation of Risk Estimation Model
Major Infection After Pediatric Cardiac Surgery: External Validation of Risk Estimation Model Andrzej Kansy, MD, PhD, Jeffrey P. Jacobs, MD, PhD, Andrzej Pastuszko, MD, PhD, Małgorzata Mirkowicz-Małek,
More informationTransfusions in Acute Care Too Little?
Transfusions in Acute Care Too Little? Keyvan Karkouti MD FRCPC MSc Associate Professor Department of Anesthesia; Department of Health Policy, Management, and Evaluation; University of Toronto Scientist
More informationUniversity of Wisconsin - Madison Cardiovascular Medicine Fellowship Program UW CICU Rotation Goals and Objectives
Background: The field of critical care cardiology has evolved considerably over the past 2 decades. Contemporary critical care cardiology is increasingly focused on the management of patients with advanced
More informationCIPG Transcatheter Aortic Valve Replacement- When Is Less, More?
CIPG 2013 Transcatheter Aortic Valve Replacement- When Is Less, More? James D. Rossen, M.D. Professor of Medicine and Neurosurgery Director, Cardiac Catheterization Laboratory and Interventional Cardiology
More informationNCAP NATIONAL CARDIAC AUDIT PROGR AMME NATIONAL HEART FAILURE AUDIT 2016/17 SUMMARY REPORT
NCAP NATIONAL CARDIAC AUDIT PROGR AMME NATIONAL HEART FAILURE AUDIT 2016/17 SUMMARY REPORT CONTENTS PATIENTS ADMITTED WITH HEART FAILURE...4 Demographics... 4 Trends in Symptoms... 4 Causes and Comorbidities
More informationTransfusion for the sickest ICU patients: Are there unanswered questions?
Transfusion for the sickest ICU patients: Are there unanswered questions? Tim Walsh Professor of Critical Care Edinburgh University None Conflict of Interest Guidelines on the management of anaemia and
More informationBlood Transfusion Guidelines in Clinical Practice
Blood Transfusion Guidelines in Clinical Practice Salwa Hindawi Director of Blood Transfusion Services Associate Professor in Haematology and Transfusion Medicine King Abdalaziz University, Jeddah Saudi
More information